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Abstract 
Background: To evaluate the ability of the central venous-to-arterial CO2 content and tension differences to arte-
riovenous oxygen content difference ratios (∆ContCO2/∆ContO2 and ∆PCO2/∆ContO2, respectively), blood lactate 
concentration, and central venous oxygen saturation (ScvO2) to detect the presence of global anaerobic metabolism 
through the increase in oxygen consumption (VO2) after an acute increase in oxygen supply (DO2) induced by vol-
ume expansion (VO2/DO2 dependence).
Methods: We prospectively studied 98 critically ill mechanically ventilated patients in whom a fluid challenge was 
decided due to acute circulatory failure related to septic shock. Before and after volume expansion (500 mL of colloid 
solution), we measured cardiac index, VO2, DO2, ∆ContCO2/∆ContO2 and ∆PCO2/∆ContO2 ratios, lactate, and ScvO2. 
Fluid-responders were defined as a ≥15 % increase in cardiac index. Areas under the receiver operating characteristic 
curves (AUC) were determined for these variables.
Results: Fifty-one patients were fluid-responders (52 %). DO2 increased significantly (31 ± 12 %) in these patients. 
An increase in VO2 ≥ 15 % (“VO2-responders”) concurrently occurred in 57 % of the 51 fluid-responders (45 ± 16 %). 
Compared with VO2-non-responders, VO2-responders were characterized by higher lactate levels and higher 
∆ContCO2/∆ContO2 and ∆PCO2/∆ContO2 ratios. At baseline, lactate predicted a fluid-induced increase in VO2 ≥ 15 % 
with AUC of 0.745. Baseline ∆ContCO2/∆ContO2 and ∆PCO2/∆ContO2 ratios predicted an increase of VO2 ≥ 15 % with 
AUCs of 0.965 and 0.962, respectively. Baseline ScvO2 was not able to predict an increase of VO2 ≥ 15 % (AUC = 0.624).
Conclusions: ∆ContCO2/∆ContO2 and ∆PCO2/∆ContO2 ratios are more reliable markers of global anaerobic metabo-
lism than lactate. ScvO2 failed to predict the presence of global tissue hypoxia.
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Background
The aim of volume expansion, during acute circulatory 
failure, is to increase cardiac index (CI) and oxygen deliv-
ery (DO2) and to improve tissue oxygenation. Unrecog-
nizable and untreated global tissue hypoxia is thought to 
contribute to the development of multiple organ failure 
or death. The usual indicators of global tissue hypoxia, 
such as blood lactate and venous oxygen saturation, are 
misleading. Increased lactate levels in sepsis are tradi-
tionally viewed as the result of activation of anaerobic 
glycolysis pathway due to inadequate oxygen delivery. 
According to such paradigms, hyperlactatemia signals 
tissue hypoxia and hypoperfusion [1, 2]. Nevertheless, in 
septic states, lactate concentration may increase through 
other mechanisms unrelated to tissue oxygen debt [3, 4]. 
Therefore, hyperlactatemia does not necessarily reflect 
anaerobic metabolism secondary to cellular hypoxia.
Measurement of mixed or central venous oxygen satu-
ration (ScvO2) has been advocated in order to detect 
global tissue hypoxia [5]. ScvO2 reflects the balance 
between oxygen consumption and supply. A low ScvO2 
represents a high oxygen extraction (OE) in order to 
maintain oxygen consumption (VO2) in spite of low DO2. 
However, a low ScvO2 does not necessarily indicate the 
presence of VO2/DO2 dependency. It is when ScvO2 
cannot decrease proportionally to the decline of DO2 to 
maintain VO2, that cell moves from aerobic to anaerobic 
metabolism, leading to tissue hypoxia [6]. On the other 
hand, in septic shock, due to impairment of OE, normal/
high ScvO2 values can also be observed in the presence of 
oxygen debt [5, 6]. Therefore, other markers are needed 
to indicate the presence of anaerobic metabolism in criti-
cally ill patients.
Considering the ratio of the venous-to-arterial CO2 
tension difference (∆PCO2) over the arterial-to-venous 
oxygen content difference (∆ContO2) as a surrogate of 
the respiratory quotient (RQ), it has been suggested that 
this ratio can be used as a marker of global anaerobic 
metabolism in critically ill patients [7]. Recently, Mon-
net et  al. [8] found that this ratio, calculated from cen-
tral venous blood, predicted an increase in VO2 after a 
fluid-induced increase in DO2 and, thus, can be able to 
detect the presence of global tissue hypoxia. However, 
PCO2 is not equivalent to CO2 content, and the PCO2/
CO2 content relationship is curvilinear rather than linear 
and is influenced by many factors such as pH and oxygen 
saturation (Haldane effect). Although VCO2/VO2 might 
be better reflected by the venous-to-arterial CO2 content 
over ∆ContO2 (∆ContCO2/∆ContO2) ratio, there is no 
report in the literature whether this latter ratio can pre-
dict more accurately a situation of anaerobic metabolism 
than ∆PCO2/∆ContO2 ratio. Therefore, the aim of our 
study was to evaluate the ability of ∆ContCO2/∆ContO2, 
∆PCO2/∆ContO2, ScvO2, and blood lactate to predict the 
presence of the activation of global anaerobic metabolism 
through VO2/DO2 dependence in septic shock patients. 
The presence of VO2/DO2 dependency phenomenon 
was characterized by the increase in VO2 after an acute 
increase in DO2 induced by volume expansion (VE).
Methods
This prospective single-center observational study was 
conducted in a general adult intensive care unit (ICU) 
after approval by our local institutional ethics committee 
(Lens Hospital, France). Informed consent was obtained 
from each subject’s next of kin.
Patients
We studied mechanically ventilated patients for whom 
the attending physician decided to perform a VE due to 
the presence of at least one clinical sign of inadequate tis-
sue perfusion due to septic shock [2]: (a) systolic arterial 
pressure <90 mmHg, mean arterial pressure <65 mmHg, 
or the need for vasopressor infusion; (b) skin mot-
tling; (c) lactate level >2  mmo/L; or (d) urinary output 
<0.5 mL/kg/h for ≥2 h. Septic shock was defined accord-
ing to international criteria [9]. Patients had also to be 
monitored by PiCCO device (PiCCO, Pulsion Medical 
System, Munich, Germany) as part of routine manage-
ment of persistent signs of tissue hypoperfusion in our 
ICU. Exclusion criteria were: liver failure as defined by 
Sequential Organ Failure Assessment score, pregnancy, 
age <18  years old, moribund, and risk of fluid loading-
induced pulmonary edema.
Measurements
CI was obtained with the PiCCO monitor by triplicate 
central venous injections, in either the internal jugular or 
subclavian vein, of 20 mL of iced 0.9 % saline solution and 
recorded as the average of the three measurements.
Arterial lactate levels, arterial, and central venous blood 
gas were measured using the GEM Premier 4000 (Instru-
mentation Laboratory Co, Paris, France). The central 
venous blood was obtained from a central venous catheter 
with the tip confirmed to be in the superior vena cava at 
the entrance, or in the right atrium by radiograph. The 
∆PCO2 was calculated as the difference between the cen-
tral venous carbon dioxide tension and the arterial carbon 
dioxide tension. The arterial (CaO2) and central venous 
(CcvO2) oxygen contents were calculated using the stand-
ard formulas (Additional file 1: Supplementary material). 
The ∆ContO2 (mL) was calculated as CaO2–CcvO2. The 
DO2 was calculated by using the formula: DO2 (mL/min/
m2) = CaO2 × CI × 10. The VO2 was calculated using the 
following formula: VO2 (mL/m2) = CI × ∆ContO2 × 10. 
Oxygen extraction was defined as: OE = VO2/DO2.
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We also determined the central venous-to-arterial differ-
ence in blood CO2 content [∆ContCO2] according to Doug-
las et al. [10] (Additional file 1: Supplementary material).
Study protocol
At baseline, a first set of measurements was performed, 
including hemodynamic and tissue oxygenation vari-
ables (Additional file  1: Supplementary material), arte-
rial lactate level, ∆PCO2, ∆ContCO2/∆ContO2 ratio, 
and ∆PCO2/∆ContO2 ratio. A 500 mL of colloid solution 
(4 % human serum albumin, Vialebex®; LFB) was infused 
to the patient over 15  min via a specific venous line. 
Immediately after VE, a second set of measurement was 
recorded, including the same hemodynamic and tissue 
oxygenation variables. Ventilation parameters and doses 
of norepinephrine, dobutamine, and sedation drugs were 
kept constant during the VE.
Statistical analysis
According to changes in CI after the 500-mL VE, patients 
were classified as fluid-responders (≥15  % increase in 
CI) or fluid-non-responders. Also, in the fluid-respond-
ers’ group, patients were separated into two subgroups 
according to their increase in VO2 (< or ≥15 %) induced 
by VE [8]. All data are expressed as mean  ±  SD when 
they are normally distributed, or as median [25–75  %, 
interquartile range, (IQR)] when they are non-normally 
distributed. The normality of data distribution was 
assessed using the Kolmogorov–Smirnov test. Compari-
sons of values between different groups of patients were 
made by two-tailed Student’s t test, or Mann–Whitney U 
test, as appropriate. Pairwise comparisons between dif-
ferent study times were assessed using paired Student’s t 
test or Wilcoxon’s test, as appropriate. Linear correlations 
were tested by using the Pearson or the Spearman test, 
as appropriate. To adjust for the regression to the mean 
phenomenon, the absolute change in variables over time 
was also analyzed by performing an analysis of covari-
ance (ANCOVA) with the absolute change in variable as 
dependent variable, the group of patients as a factor, and 
the baseline value as a covariate.
Receiver operating characteristics (ROC) curves were 
constructed to evaluate the ability of tissue oxygenation 
variables at baseline to predict an increase of VO2 ≥ 15 % 
after VE in fluid-responders’ group. The areas under the 
ROC curves (AUCs) were compared using the nonpara-
metric technique described by DeLong et  al. [11]. The 
best cutoff of a ROC curve was chosen with the high-
est Youden index [12]. Usually, variables are considered 
of good clinical tool (having good discriminative prop-
erties tests) when the inferior limits of the 95  % con-
fidence interval (CI) of their AUC are more than 0.75 
[12]. For this purpose, considering a proportion of VO2 
responders of 21 % [8], 51 fluid-responder’s patients are 
required for a power of 90  % and an alpha risk of 0.05. 
Assuming a proportion of responders close to 50  %, 
about 102 patients would be necessary. Statistical analysis 
was performed using STATA 14.0 (StataCorp LP, College 
Station, Texas, USA) and SPSS for Windows release 17.0 
(Chicago, Illinois, USA). p < 0.05 was considered statisti-
cally significant. All reported P values are two-sided.
Results
Patients
Ninety-eight septic shock patients were prospectively 
included in this study. The main characteristics of the 
cohort are summarized in Table  1. The median time 
between the start of care and enrollment was 1.7 [1.0–
2.0]  h. The major source of infection was pneumonia 
(55 %) with ICU mortality rate of 42.8 %.
The whole population
At baseline, there was a significant but weak correla-
tion between lactate and ∆PCO2/∆ContO2 (r  =  0.33, 
p = 0.001) and between lactate and ∆ContCO2/∆ContO2 
(r = 0.32, p = 0.001). Furthermore, fluid-induced changes 
in ∆PCO2/∆ContO2, ∆ContCO2/∆ContO2, and lactate 
were weakly correlated (r = 0.25, p = 0.01 and r = 0.21, 
p  =  0.04; respectively). We found a good correlation 
between ∆ContCO2/∆ContO2 and ∆PCO2/∆ContO2 
ratios (r  =  0.63, p  <  0.001). Fluid-induced changes in 
∆PCO2/∆ContO2 and ∆ContCO2/∆ContO2 ratios were 
also well related (r = 0.63, p < 0.001).
Effects of volume expansion on hemodynamic variables
VE increased CI by more than 15 % in 51 patients who were 
“fluid-responders” (52  %; Additional file  2: Table S1). In 
these patients, VE significantly increased CI by 30 ± 13 %, 
DO2 by 31  ±  12  %, and VO2 by 25  ±  26  % (Additional 
file 2: Table S1). Volume expansion induced less than 15 % 
increase in CI in 47 patients (48 %). In these patients, we 
observed no significant changes in DO2 and VO2.
Differences between VO2‑responders 
and VO2‑non‑responders in fluid‑responders’ group
Of the 51 fluid-responders, VE increased VO2  ≥  15  % 
(45  ±  16  %) in 29 who were “VO2-responders.” In the 
remaining 22 fluid-responders, VE did not significantly 
change VO2 “VO2-non-responders” (Table 2; Fig. 1).
At baseline, compared with the VO2-non-
responders, lactate levels and ∆PCO2/∆ContO2 and 
∆ContCO2/∆ContO2 ratios were significantly higher 
in VO2-responders, whereas ScvO2 value was not sig-
nificantly different between these two subgroups 
(Table  2). In these patients, ∆PCO2/∆ContO2 and 
∆ContCO2/∆ContO2 ratios decreased significantly by 
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30 ± 13 and 45 ± 24 % (respectively) with VE, whereas 
they did not change in VO2-non-responders (Table  2). 
ScvO2 significantly increased (22 ± 16 %) with VE only in 
VO2-non-responders (Table 2).
Lactate levels decreased significantly with VE in 
both VO2-responders and VO2-non-responders. The 
magnitude of decrease in lactate levels was not differ-
ent between these two subgroups (13  ±  7  % for VO2-
responders vs. 13  ±  10  % for VO2-non-responders, 
p = 0.98, Table 2).
Among fluid-responder patients, VE-induced changes 
in ∆PCO2/∆ContO2, ∆ContCO2/∆ContO2, and ScvO2, 
but not in lactate, were significantly higher, after adjust-
ment to their baseline values, in VO2-responders than in 
VO2-non-responders (ANCOVA, p  <  0.001, p  =  0.006, 
p < 0.001, and p = 0.18; respectively).
VE-induced change in VO2 was not significantly cor-
related with the changes in lactate (r = −0.17, p = 0.22). 
However, changes in both ∆PCO2/∆ContO2 and 
∆ContCO2/∆ContO2 ratios induced by VE were well cor-
related with changes in VO2 (r = −0.52, p < 0.001, and 
r = −0.59, p < 0.001; respectively).
Ability of tissue oxygenation variables to predict the 
response of VO2 to VE in fluid‑responders
The ability of ∆PCO2/∆ContO2 and ∆ContCO2/∆ContO2 
at baseline to predict an increase of VO2 ≥ 15 % induced 
by VE was excellent in fluid-responder patients with 
AUCs of 0.962 (95  % CI 0.900–1.000) and 0.965 (95  % 
CI 0.918–1.000), respectively (Fig.  2). The AUC for 
baseline value of lactate was 0.745 [(95  % CI 0.608–
0.883), p = 0.003 vs. 0.5]. However, ScvO2 at baseline did 
not predict the VO2 increase of ≥15  % [AUC  =  0.624, 
(95 % CI 0.449–0.798), p = 0.14 vs. 0.5].
AUCs for baseline ∆PCO2/∆ContO2 and 
∆ContCO2/∆ContO2 ratios were both significantly 
larger than the AUCs for baseline lactate (p = 0.003 and 
p = 0.002, respectively) and baseline ScvO2 (p < 0.001 for 
both ratios, Fig.  2). However, there were no significant 
differences between AUC for ∆PCO2/∆ContO2 and AUC 
for ∆ContCO2/∆ContO2 (p  =  0.80), neither between 
AUC for baseline lactate and AUC for baseline ScvO2 
(p = 0.24).
The best cutoff values at baseline, when predict-
ing VO2 responsiveness, were ≥1.68  mmHg/mL for 
∆PCO2/∆ContO2 ratio [sensitivity  =  90  % (95  % CI 
71–97 %); specificity = 100 % (95 %CI 81–100 %)], ≥1.02 
for ∆ContCO2/∆ContO2 ratio [sensitivity =  86 % (95 % 
CI 67–95  %); specificity =  100  % (95  % CI 81–100  %)], 
and ≥4.6  mmol/L for lactate [sensitivity  =  69  % (95  % 
CI 49–84  %); specificity  =  77  % (95  % CI 54–91  %)] 
(Table  3). Even though the AUC for baseline ScvO2 
was not significantly different from 0.5, a ScvO2 value 
≥80  % had a specificity of 100  % (95  % CI 81–100  %) 
but a sensitivity of 21 % (95 % CI 9–40 %) to predict the 
VO2 increase ≥15 %. Thus, in fluid-responders, a ScvO2 
value ≥80  % was always associated with an increase in 
VO2  ≥  15  % induced by VE. Compared with patients 
with a baseline ScvO2 < 80 %, these patients had higher 
baseline lactate levels [4.3 (2.3–6.3) mmol/L vs. 7.6 (5.6–
8.1) mmol/L, p  =  0.011; respectively], higher baseline 
∆PCO2/∆ContO2 ratio [1.46 (1.05–2.17) mmHg/mL vs. 
2.20 (2.20–2.38) mmHg/mL, p = 0.011; respectively], and 
higher baseline ∆ContCO2/∆ContO2 ratio [0.94 (0.53–
1.05) vs. 1.52 (1.42–1.62), p < 0.001; respectively].
Comparisons between patients with ScvO2 > 70 % 
and patients with ScvO2 ≤ 70 % at baseline in the whole 
population
Only 28 patients had a ScvO2 of more than 70 % at base-
line (Additional file  3: Table S2). They had significantly 
lower baseline VO2 and higher baseline DO2 compared 
with patients with low baseline ScvO2. The mean baseline 
value of VO2 significantly increased with volume expan-
sion only in patients with ScvO2 > 70 % (Additional file 3: 
Table S2).
Discussion
The main findings of our study were that in fluid-
responder septic shock patients (1) the ability of 
∆ContCO2/∆ContO2 and ∆PCO2/∆ContO2 ratios 
to predict the presence of global anaerobic metab-
olism was excellent and higher than lactate; (2) 
Table 1 Baseline characteristics of the patients (n = 98)
IQR interquartile range, ICU intensive care unit
Age (mean ± SD, years) 63 ± 11
Body masse index (mean ± SD, kg/m2) 26.6 ± 5.4
Gender (female/male) (n) 41/57
Simplified acute physiologic score (mean ± SD) 64 ± 18
Sequential organ failure assessment  
score (median [IQR])
10 [6–12]
ICU mortality [n (%)] 42 (42.8)
Time between diagnosis and inclusion  
(median [IQR], h)
1.7 [1.0–2.0]




Urinary tract infection 5 (5)
Patients receiving norepinephrine [n (%)] 98 (100)
Norepinephrine dose (median [IQR], µg/kg/min) 0.24 [0.11–0.55]
Patients receiving dobutamine [n (%)] 21 (21.4)
Dobutamine dose (median [IQR], µg/kg/min) 5 [5–10]
Mechanical ventilation [n (%)] 98 (100)
Page 5 of 9Mallat et al. Ann. Intensive Care  (2016) 6:10 
∆ContCO2/∆ContO2 ratio was not a better marker of 
global anaerobic metabolism than ∆PCO2/∆ContO2 
ratio; (3) ScvO2 failed to detect the presence of global tis-
sue hypoxia, except for values ≥80 %.
When DO2 is acutely reduced, VO2 remains stable 
(oxygen supply independency) because the tissues adapt 
their OE proportionally. When DO2 falls below a criti-
cal low value, a proportionate increase in OE cannot 
be maintained and the VO2 starts to fall (oxygen supply 
dependency) and tissue hypoxia occurs as reflected by an 
abrupt increase in blood lactate concentration [13–15]. 
Thus, VO2/DO2 dependence has been considered to be a 
hallmark of tissue hypoxia and the activation of anaero-
bic metabolism [14–16], although it has been challenged 
because of the methodological limitations (mathematical 
coupling) in the VO2/DO2 relationship assessment [17, 
18].
We defined an increase in VO2 ≥  15  % as a clinically 
significant augmentation by similarity to the definition 
of the increase in cardiac index, since VO2 is propor-
tional to this variable. This cutoff value was chosen by the 
fact that the least significant change in CI measured by 
transpulmonary thermodilution is 11.0  % when 20  mL 
is used to perform iced saline injections in triplicate 
(unpublished data). On the other hand, this definition of 
“VO2 response” allows us comparing our findings with 
those of a previous study [8]. We confirm the results of 
Monnet et  al. [8] that calculating VO2 from the central 
Table 2 Hemodynamic and  tissue oxygenation parameters before  and after  500  mL of  volume expansion according 
to the response of VO2 in fluid-responder patients
Data are expressed as mean ± SD or as median [interquartile range, 25–75]
SaO2 arterial oxygen saturation, CaO2 arterial oxygen content, PaCO2 arterial carbon dioxide tension, ScvO2 central venous oxygen saturation, CcvO2 central venous 
oxygen content, PcvCO2 central venous carbon dioxide tension, DO2 oxygen delivery, VO2 oxygen consumption, ∆PCO2 venous–arterial carbon dioxide tension 
difference, CaCO2 arterial carbon dioxide content, CcvCO2 central venous carbon dioxide content, ∆ContO2 arterial-to-central venous oxygen content difference, 
∆ContCO2 central venous-to-arterial carbon dioxide content difference, OE oxygen extraction
* p < 0.05 after vs. before volume expansion. # p < 0.05 patients with a VO2 < 15 % versus patients with a VO2 ≥ 15 %
VO2 change ≥15 % (n = 29) VO2 change <15 % (n = 22)
Before volume  
expansion
After volume  
expansion




Heart rate (beats/min) 108 ± 34 102 ± 26* 110 ± 27 109 ± 26
Mean arterial pressure (mmHg) 66 ± 16 79 ± 13* 74 ± 13 85 ± 10*
Cardiac index (L/min/m2) 2.59 [1.42–3.03] 3.02 [2.09–3.71]* 3.25 [2.49–3.65]# 3.81 [3.48–4.23]#,*
Stroke index (mL/m2) 19.4 [13.1–35.9] 27.0 [22.5–43.8]* 30.8 [21.5–34.1]# 41.0 [31.6–41.4]*
Minute ventilation (L/min) 10.4 ± 2.0 – 8.5 ± 1.5# –
Arterial pH 7.35 [7.32–7.38] 7.36 [7.35–7.37] 7.23 [7.21–7.30]# 7.22 [7.22–7.31]#
Base excess (mmol/L) –7.21 ± 4.74 –7.11 ± 4.21 –8.15 ± 4.20 –8.25 ± 3.89
SaO2 (%) 99 [90–100] 98 [94–100] 94 [91–96]
# 95 [92–98]#,*
Hemoglobin (g/dL) 10.1 ± 1.3 9.5 ± 1.1* 10.7 ± 1.0 10.1 ± 0.9#,*
CaO2 (mL) 12.8 ± 2.0 12.8 ± 1.7 13.2 ± 1.4 13.2 ± 1.2
PaCO2 31 ± 5 31 ± 6 43 ± 8# 42 ± 7#
CaCO2 (mL) 37.1 [30.0–49.2] 37.2 [28.8–46.4]* 40.5 [35.6–46.9] 37.2 [34.9–42.8]*
Venous pH 7.31 [7.24–7.34] 7.33 [7.27–7.33] 7.22 [7.18–7.24]# 7.21 [7.20–7.27]#,*
ScvO2 (%) 63 ± 11 63 ± 10 58 ± 14 69 ± 10#,*
CcvO2 (mL) 8.4 ± 2.0 8.1 ± 1.6* 8.2 ± 2.2 9.6 ± 1.8#,*
PcvCO2 (mmHg) 40 ± 7 38 ± 7* 49 ± 7# 47 ± 6#,*
CcvCO2 (mL) 43.4 [35.1–53.3] 41.4 [31.8–49.6]* 43.6 [40.2–47.3] 39.9 [37.9–43.3]*
DO2 (mL/min/m
2) 297 ± 86 381 ± 84* 409 ± 80# 529 ± 84#,*
VO2 (mL/min/m
2) 95 ± 27 134 ± 30* 148 ± 43# 145 ± 37
OE 0.34 ± 0.11 0.37 ± 0.10* 0.37 ± 0.15 0.28 ± 0.09#,*
∆PCO2 (mmHg) 7.0 [6.0–14.0] 6.0 [5.0–12.0]* 4.0 [3.7–9.0]
# 3.0 [3.0–6.0]#,*
∆ContO2 (mL) 4.3 ± 1.6 4.7 ± 1.4* 5.0 ± 2.1 3.7 ± 1.1#,*
∆ContCO2 (mL) 5.2 [3.9–6.3] 3.0 [2.8–4.2]* 1.8 [0.3–4.7]
# 1.5 [0.5–3.3]#,*
∆PCO2/∆ContO2 (mmHg/mL) 2.20 [1.70–2.33] 1.66 [1.10–1.96]* 1.05 [1.02–1.14]
# 1.13 [0.83–1.35]#
∆ContCO2/∆ContO2 1.22 [1.05–1.26] 0.65 [0.65–0.70]* 0.53 [0.09–0.64]
# 0.46 [0.14–0.70]#
Lactate (mmol/L) 5.8 [3.2–7.6] 5.0 [2.8–6.9]* 2.9 [2.1–4.9]# 2.7 [1.4–4.4]#,*
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instead of the mixed venous blood also allows to detect 
the presence of anaerobic metabolism through VO2/DO2 
dependence. Indeed, in our study, the baseline lactate 
concentration was elevated in patients with VO2/DO2 
dependency phenomenon and higher than in patients 
with VO2/DO2 independency (Table  2). Moreover, it is 
hard to believe that mathematical coupling of measure-
ment errors was responsible for the VO2/DO2 depend-
ency in our study. Indeed, we observed that VO2/DO2 
dependency occurred in one subgroup of patients but 
not in others, despite similar changes in DO2 (Table  2). 
Such a methodological problem can hardly account for 
the existence of VO2/DO2 dependency only in one sub-
group. If that were an issue, one would expect it to influ-
ence results uniformly. Finally, the increase in VO2 could 
have resulted from an additional non-mitochondrial non-
oxidative oxygen uptake when dysoxia has resolved [19]. 
However, this mechanism is less likely to have occurred 
in our study because the observed mean slope of the 
VO2/DO2 relationship in the subgroup of VO2-respond-
ers was 47.8  ±  10  %, suggesting VO2/DO2 dependency 
and activation of anaerobic metabolism (Table 2) [20].
In experimental conditions of tissue hypoxia, a smaller 
reduction in VCO2 than VO2 has been observed, sug-
gesting a non-aerobic production of CO2 [21–23]. There-
fore, the occurrence of a high RQ may be considered as 
a sign of anaerobic metabolism. Recently, Monnet et  al. 
[8] have used the ∆PCO2/∆ContO2 ratio as a surrogate 
of RQ and found that a ∆PCO2/∆ContO2 ratio at base-
line  ≥  1.8  mmHg/mL predicted accurately VO2/DO2 
dependence among patients whose DO2 increased after 
fluid administration. Our results agree with those find-
ings, and interestingly, the observed cutoff value of this 
ratio, in our septic shock patients, was almost similar to 
what was found in the Monnet et al. report [8].
The use of ∆PCO2/∆ContO2 ratio as a surrogate of 
VCO2/VO2 assumes that the PCO2/CO2 content rela-
tionship is quasi-linear, which may be true over the 
physiologic range of PCO2 [24]. However, this relation-
ship can be affected by the degree of metabolic acidosis, 
Fig. 1 Flow chart showing the original 98 patients separated accord-
ing to their response to volume expansion in terms of cardiac index, 
fluid responsiveness, and oxygen consumption (VO2)
Fig. 2 Receiver operating characteristic (ROC) curves showing the 
ability of baseline ∆ContCO2/∆ContO2, ∆PCO2/∆ContO2, lactate, 
and ScvO2 to predict an increase in oxygen consumption of ≥15 % 
induced by volume expansion
Table 3 Diagnostic ability of baseline values of central venous-to-arterial CO2 tension and content differences to arterial-
to-venous oxygen content difference ratios, and baseline lactate values to predict fluid-induced increase in oxygen con-
sumption ≥15 % in fluid-responder patients (n = 51)
Se sensitivity, Sp specificity, PPV positive predictive value, NPV negative predictive value, LR+ positive likelihood ratio, LR− negative likelihood ratio, CI confidence 
interval
Best cutoff  
value
Se (%)  
(95 % CI)
Sp (%)  
(95 % CI)
PPV (%)  
(95 % CI)








1.68 90 (71–97) 100 (81–100) 100 (84–100) 88 (68–97) Infinity 0.10 (0.03–0.30)
∆ContCO2/∆ContO2 1.02 86 (67–95) 100 (81–100) 100 (83–100) 85 (64–95) Infinity 0.14 (0.05–0.34)
Lactate (mmol/L) 4.6 69 (49–84) 77 (54–91) 80 (59–92) 65 (44–82) 3.03 (1.35–6.81) 0.40 (0.23–0.71)
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hematocrit, and oxygen saturation (Haldane effect), and 
it becomes nonlinear if these factors change [25]. In this 
regard, it has been shown that venous-to-arterial PCO2 
differences and venous-to-arterial CO2 content differ-
ences might change in opposite direction in splanchnic 
region under conditions of very low venous oxygen satu-
ration [26]. Recently, Ospina-Tascon et al. found a signifi-
cant association with mortality, in septic shock patients, 
for the mixed ∆ContCO2/mixed ∆ContO2 ratio but not 
for the mixed ∆PCO2/mixed ∆ContO2 ratio [27]. Thus, 
∆ContCO2/∆ContO2 ratio could be a more reliable 
marker of tissue hypoxia than ∆PCO2/∆ContO2. How-
ever, we found that ∆ContCO2/∆ContO2 was not better 
predictor of tissue hypoxia than the ∆PCO2/∆ContO2 in 
septic shock patients (Fig. 2). It does not seem that Hal-
dane effect has played an important role in our study. Fur-
thermore, the degree of metabolic acidosis, as reflected 
by base excess, was not severe enough to significantly 
affect the PCO2/CO2 content relationship in our septic 
shock patients. Even though the ∆ContCO2/∆ContO2 
ratio more physiologically mirrors RQ compared with 
∆PCO2/∆ContO2, we found that both ratios can be used 
accurately to predict fluid responsiveness at tissue level. 
However, the computation of ∆PCO2/∆ContO2 ratio is 
less cumbersome and less subject to the risk of errors, 
and therefore, it is much easier to be used at the bedside.
Lactate value was not good to detect the presence 
of anaerobic metabolism in our septic shock patients. 
Our results are in discrepancy with previous findings 
[7, 8, 28]. However, hyperlactatemia does not necessar-
ily reflect anaerobic metabolism secondary to tissue 
hypoxia, especially in septic states [3, 4, 29]. Other non-
hypoxic mechanisms such as accelerated aerobic gly-
colysis induced by sepsis-associated inflammation [30], 
inhibition of pyruvate dehydrogenase [31], and impaired 
lactate clearance [32] may contribute to hyperlactatemia 
found in septic patients. In endotoxic states, lactate lev-
els failed to discriminate between hypoxia and aero-
biosis [33]. Furthermore, Rimachi et  al. [34] found the 
presence of hyperlactatemia in 65  % of septic shock 
patients, but only 76 % of these patients also had a high 
lactate/pyruvate ratio confirming the non-hypoxic cause 
of hyperlactatemia in septic states. Moreover, in fluid-
responder patients, we found no significant relationship 
between changes in VO2 induced by VE and changes in 
lactate levels, whereas changes in ∆PCO2/∆ContO2 and 
∆ContCO2/∆ContO2 ratios were correlated well with 
changes in VO2. This finding suggests that these ratios 
respond to changes in global tissue oxygenation faster 
than blood lactate concentration likely due to the altera-
tion of lactate clearance.
The majority (71 %) of our septic shock patients had a 
ScvO2 value ≤70  % at their inclusion in the study. This 
finding is due to the fact that patients, in our study, were 
recruited in the very early period of acute circulatory 
failure; the time between the start of care and enroll-
ment was only 102 min. Within this period, septic shock 
patients are not fully resuscitated yet, and as a conse-
quence, low values of ScvO2 are observed more fre-
quently [35–37]. Even though our population seems to be 
different from that in the study of Monnet et al. [8], we 
confirm that ScvO2 is a poor predictor of the presence of 
anaerobic metabolism. This can be explained by the fact 
that ScvO2 is not a regulated parameter but an adaptive 
one that depends on four regulated constituents: oxygen 
consumption, hemoglobin, SaO2, and cardiac output. 
Therefore, ScvO2 is widely fluctuating. However, these 
results should not dissuade us from monitoring ScvO2 
but encourage us to include it in a multimodal approach. 
Indeed, a low ScvO2 value reflects the inadequacy of 
oxygen supply, and fluid administration can be helpful 
in order to correct oxygen supply/demand imbalance, 
even in  situations of VO2/DO2 independency, to avoid 
further decreases in DO2 below a critical value leading 
to tissue hypoxia. On the other hand, only ScvO2 values 
≥80 % were able to predict the presence of global tissue 
hypoxia with a high specificity. All these patients also 
had higher lactate levels and higher ∆PCO2/∆ContO2 
and ∆ContCO2/∆ContO2 ratios. This suggests that these 
patients had a greater alteration of their microcircula-
tion due to sepsis than the other fluid-responder patients. 
However, this finding should be interpreted with cau-
tion, since only six patients had a baseline ScvO2 value 
≥80 % in fluid-responders’ group, and our study was not 
designed for testing this hypothesis.
Contrary to what was found previously [8], DO2 did 
not decrease during VE, in fluid-non-responder patients, 
even though arterial hemoglobin significantly decreased 
by 5.6  ±  4.6  % (Additional file  2: Table S1), which was 
lower than that in the Monnet et al. study (8 ± 4 %) [8]. 
The discrepancy between the two studies may be due to 
dissimilar populations of patients and to the differences 
in the time to inclusion, which was longer in the study 
by Monnet et al. [8] than that in our study (6.1 vs. 1.7 h) 
explaining the more pronounced hemodilution effect in 
their study.
We believe our findings add significant values to the 
Monnet et  al. study [8]. Indeed, we have demonstrated 
that the ∆PCO2/∆ContO2 ratio is a reliable marker of 
global anaerobic metabolism in the very early period of 
septic shock where patients are still not fully resusci-
tated and that ∆ContCO2/∆ContO2 is not superior to 
∆PCO2/∆ContO2 for predicting the presence of global 
tissue hypoxia in these patients. Furthermore, our study 
shed the light on the fact that hyperlactatemia should not 
always be regarded as reflecting the presence of global 
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tissue hypoxia, especially in septic shock patients. This 
finding is of clinical importance since elevated lactate val-
ues could incite the clinician to undertake unnecessary 
interventions, with their potentially harmful effects, such 
as tissue edema and positive fluid balance, which have 
constantly been associated with poorer outcome [38].
Our study presents several limitations. First, we used 
central venous blood instead of mixed venous to assess 
VO2- and CO2-derived variables, and thus, we might have 
missed the evaluation of the splanchnic oxygenation. How-
ever, our study is the second one that confirms that calcu-
lating oxygen-derived variables from the central venous 
blood is able to detect the presence of tissue hypoxia 
through VO2/DO2 dependence. Second, regional or local 
tissue hypoxia might not be detected by the assessment of 
the changes in global oxygen consumption. Finally, it is a 
single-center study, which may limit its external validity.
Conclusion
∆ContCO2/∆ContO2 and ∆PCO2/∆ContO2 are excellent 
and better markers of global anaerobic metabolism than 
lactate in fluid-responder septic shock patients. Also, 
these parameters respond to changes in global oxygena-
tion faster than lactate. ScvO2 cannot predict the pres-
ence of global tissue hypoxia, except for values ≥80 %.
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